Publicaciones en colaboración con investigadores/as de Hospital Universitario Puerta de Hierro (49)

2024

  1. Baroreflex activation therapy in patients with heart failure and reduced ejection fraction

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 342-344

  2. Clinical impact of remote heart failure management using the multiparameter ICD HeartLogic alert

    Revista Espanola de Cardiologia

  3. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure

    ESC Heart Failure, Vol. 11, Núm. 3, pp. 1767-1776

  4. Efficacy and safety of hypertonic saline therapy in ambulatory patients with heart failure: The SALT-HF trial

    European Journal of Heart Failure

  5. Influence of the medical treatment schedule in new diagnoses patients with heart failure and reduced ejection fraction

    Clinical Research in Cardiology, Vol. 113, Núm. 8, pp. 1171-1182

  6. Prognostic Utility of Society for Cardiovascular Angiography and Interventions Shock Stage Approach for Classifying Cardiogenic Shock Severity in Takotsubo Syndrome

    Journal of the American Heart Association, Vol. 13, Núm. 6, pp. e032951

  7. Renal impairment and outcome in Takotsubo syndrome: Insights from a national multicentric cohort

    International Journal of Cardiology, Vol. 405

  8. Repetitive ambulatory levosimendan as a bridge to heart transplantation

    Revista Espanola de Cardiologia, Vol. 77, Núm. 4, pp. 290-301

  9. Review of the allocation criteria for heart transplant in Spain in 2023. SEC-Heart Failure Association/ONT/SECCE consensus document

    Revista Espanola de Cardiologia, Vol. 77, Núm. 1, pp. 69-78

2023

  1. Conduction system pacing and atrioventricular node ablation in heart failure: The PACE-FIB study design

    ESC Heart Failure, Vol. 10, Núm. 6, pp. 3700-3709

  2. De Novo Donor-Specific Antibodies after Heart Transplantation: A Comprehensive Guide for Clinicians

    Journal of Clinical Medicine, Vol. 12, Núm. 23

  3. Do Women Physicians Accept and Follow Heart Failure Guidelines More Than Men?

    Current Heart Failure Reports, Vol. 20, Núm. 3, pp. 151-156

  4. Impact of Advanced Age on the Incidence of Major Adverse Cardiovascular Events in Patients with Type 2 Diabetes Mellitus and Stable Coronary Artery Disease in a Real-World Setting in Spain

    Journal of Clinical Medicine, Vol. 12, Núm. 16

  5. Intermittent inotropic support with levosimendan in advanced heart failure as destination therapy: The LEVO-D registry

    ESC Heart Failure, Vol. 10, Núm. 2, pp. 1193-1204

  6. Opinion on the 2021 ESC guidelines on heart failure: a cross-sectional survey of 387 doctors

    REC: CardioClinics, Vol. 58, Núm. 1, pp. 7-15

  7. Vericiguat in the current management of the patients with heart failure

    REC: CardioClinics

2022

  1. Antiplatelet therapy and outcome in COVID-19: the Health Outcome Predictive Evaluation Registry

    Heart (British Cardiac Society), Vol. 108, Núm. 2, pp. 130-136

  2. Aspirin Therapy on Prophylactic Anticoagulation for Patients Hospitalized With COVID-19: A Propensity Score-Matched Cohort Analysis of the HOPE-COVID-19 Registry

    Journal of the American Heart Association, Vol. 11, Núm. 13

  3. Assessment of medical management in Coronary Type 2 Diabetic patients with previous percutaneous coronary intervention in Spain: A retrospective analysis of electronic health records using Natural Language Processing

    PLoS ONE, Vol. 17, Núm. 2 February

  4. Chronic Oral Anticoagulation Therapy and Prognosis of Patients Admitted to Hospital for COVID-19: Insights from the HOPE COVID-19 Registry

    International Journal of Clinical Practice, Vol. 2022